The genes in which the polymorphisms described reside in are TNRC9, FGFR2, MAP3K1, H19 and LSP1. The most strongly associated SNP is localized in gene FGFR2, which was overexpressed in 5-10 % of the cases of breast cancer. This evidence concerns the gene MAP3K1 and breast carcinoma.